These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2742818)
21. ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets. Timmons S; Kloczewiak M; Hawiger J Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4935-9. PubMed ID: 6087354 [TBL] [Abstract][Full Text] [Related]
22. A discrete sequence in a platelet integrin is involved in ligand recognition. D'Souza SE; Ginsberg MH; Matsueda GR; Plow EF Nature; 1991 Mar; 350(6313):66-8. PubMed ID: 2002847 [TBL] [Abstract][Full Text] [Related]
23. Thrombospondin binding to specific sequences within the A alpha- and B beta-chains of fibrinogen. Bacon-Baguley T; Ogilvie ML; Gartner TK; Walz DA J Biol Chem; 1990 Feb; 265(4):2317-23. PubMed ID: 2298752 [TBL] [Abstract][Full Text] [Related]
24. Fibrin(ogen) peptide B beta 15-42 inhibits platelet aggregation and fibrinogen binding to activated platelets. Chen CS; Chou SH; Thiagarajan P Biochemistry; 1988 Aug; 27(16):6121-6. PubMed ID: 3191112 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp. Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596 [TBL] [Abstract][Full Text] [Related]
26. Differential structural requirements for fibrinogen binding to platelets and to endothelial cells. Tranqui L; Andrieux A; Hudry-Clergeon G; Ryckewaert JJ; Soyez S; Chapel A; Ginsberg MH; Plow EF; Marguerie G J Cell Biol; 1989 Jun; 108(6):2519-27. PubMed ID: 2738096 [TBL] [Abstract][Full Text] [Related]
27. Further studies on the topography of the N-terminal region of human platelet glycoprotein IIIa. Localization of monoclonal antibody epitopes and the putative fibrinogen-binding sites. Calvete JJ; Arias J; Alvarez MV; Lopez MM; Henschen A; González-RodrĂguez J Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):457-63. PubMed ID: 1706596 [TBL] [Abstract][Full Text] [Related]
28. The C-terminal sequences of the gamma 57.5 chain of human fibrinogen constitute a plasmin sensitive epitope that is exposed in crosslinked fibrin. Haidaris PJ; Peerschke EI; Marder VJ; Francis CW Blood; 1989 Nov; 74(7):2437-44. PubMed ID: 2478231 [TBL] [Abstract][Full Text] [Related]
29. Adhesive ligand binding to integrin alpha IIb beta 3 stimulates tyrosine phosphorylation of novel protein substrates before phosphorylation of pp125FAK. Huang MM; Lipfert L; Cunningham M; Brugge JS; Ginsberg MH; Shattil SJ J Cell Biol; 1993 Jul; 122(2):473-83. PubMed ID: 7686553 [TBL] [Abstract][Full Text] [Related]
30. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins. Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494 [TBL] [Abstract][Full Text] [Related]
31. The synthetic RGDS peptide inhibits the binding of fibrinogen lacking intact alpha chain carboxyterminal sequences to human blood platelets. Peerschke EI; Galanakis DK Blood; 1987 Mar; 69(3):950-2. PubMed ID: 3814824 [TBL] [Abstract][Full Text] [Related]
32. Interaction of fibrinogen with staphylococcal clumping factor and with platelets. Hawiger J; Kloczewiak M; Timmons S; Strong D; Doolittle RF Ann N Y Acad Sci; 1983 Jun; 408():521-35. PubMed ID: 6223560 [TBL] [Abstract][Full Text] [Related]
33. An echistatin C-terminal peptide activates GPIIbIIIa binding to fibrinogen, fibronectin, vitronectin and collagen type I and type IV. Wright PS; Saudek V; Owen TJ; Harbeson SL; Bitonti AJ Biochem J; 1993 Jul; 293 ( Pt 1)(Pt 1):263-7. PubMed ID: 7687129 [TBL] [Abstract][Full Text] [Related]
34. Localization of the domains of fibrin involved in binding to platelets. Hantgan RR Biochim Biophys Acta; 1988 Jan; 968(1):36-44. PubMed ID: 2827787 [TBL] [Abstract][Full Text] [Related]
35. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom. Huang TF; Wang WJ; Teng CM; Ouyang C Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664 [TBL] [Abstract][Full Text] [Related]
36. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom. Huang TF; Sheu JR; Teng CM Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):351-7. PubMed ID: 1859363 [TBL] [Abstract][Full Text] [Related]
37. Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Farrell DH; Thiagarajan P; Chung DW; Davie EW Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10729-32. PubMed ID: 1438269 [TBL] [Abstract][Full Text] [Related]
38. Evidence that three adhesive proteins interact with a common recognition site on activated platelets. Plow EF; Srouji AH; Meyer D; Marguerie G; Ginsberg MH J Biol Chem; 1984 May; 259(9):5388-91. PubMed ID: 6325435 [TBL] [Abstract][Full Text] [Related]
39. gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors. Hawiger J; Timmons S; Kloczewiak M; Strong DD; Doolittle RF Proc Natl Acad Sci U S A; 1982 Mar; 79(6):2068-71. PubMed ID: 6281794 [TBL] [Abstract][Full Text] [Related]
40. Strong inhibition of fibrinogen binding to platelet receptor alpha IIb beta 3 by RGD sequences installed into a presentation scaffold. Lee G; Chan W; Hurle MR; DesJarlais RL; Watson F; Sathe GM; Wetzel R Protein Eng; 1993 Sep; 6(7):745-54. PubMed ID: 8248098 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]